{"name":"A.O.U. Città della Salute e della Scienza","slug":"a-o-u-citt-della-salute-e-della-scienza","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Bentelan","genericName":"Bentelan","slug":"bentelan","indication":"Other","status":"phase_3"},{"name":"Dialysis Solutions","genericName":"Dialysis Solutions","slug":"dialysis-solutions","indication":"Other","status":"phase_2"},{"name":"Intranasal glugagon","genericName":"Intranasal glugagon","slug":"intranasal-glugagon","indication":"Other","status":"marketed"},{"name":"Intravenous Infusion of Diclofenac Sodium","genericName":"Intravenous Infusion of Diclofenac Sodium","slug":"intravenous-infusion-of-diclofenac-sodium","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Bentelan","genericName":"Bentelan","slug":"bentelan","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dialysis Solutions","genericName":"Dialysis Solutions","slug":"dialysis-solutions","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intranasal glugagon","genericName":"Intranasal glugagon","slug":"intranasal-glugagon","phase":"marketed","mechanism":"Liver","indications":[],"catalyst":""},{"name":"Intravenous Infusion of Diclofenac Sodium","genericName":"Intravenous Infusion of Diclofenac Sodium","slug":"intravenous-infusion-of-diclofenac-sodium","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1aNnEyd1dDV014am1uWW5MYmR0aklMb0lpajFPSXhCLVF0Tnk0bGN3cFhBSHRCTVJJekRxSTdDci1wTW5VakNsR3VhSXFZRWVUeTdLekZRbG94NVkxanZ3?oc=5","date":"2025-12-30","type":"pipeline","source":"nature.com","summary":"Utility of plasma MicroRNA profiling as diagnostic biomarker in immune system activation and inflammation and early predictor of severity in patients with COVID-19 - nature.com","headline":"Utility of plasma MicroRNA profiling as diagnostic biomarker in immune system activation and inflammation and early pred","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBINFZBbHQydGpuTXJ4UTBRTGFiMi01VU5VT3M3cHUwVXJJVkhfdTU3cEZ4S0k3V21SNk9nWWc2bjl4c283dHc4SmJmcDFnSGw5NkVPaUVOSzNYQjJ6QzlN?oc=5","date":"2025-11-07","type":"trial","source":"nature.com","summary":"The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial | Leukemia - nat","headline":"The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term re","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1zbC02SFdDN0dpLUN6ZW5LUm5IUnhzNGlSZ3RSV2d1OHRZUmFDMUZZYW4wMGVGaURVVDh4NkVncDlXV2tVSTZ0ZlpWUUpNcGJocWdQU1pmTVdxeTczZl9RdjFjdVBuWEpRMWhuelFNYVgwUU5hdENIaDM3aw?oc=5","date":"2025-06-29","type":"trial","source":"Wiley","summary":"Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus - Wiley","headline":"Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxQUTA4Tl9hNkxZRlZiZmhzeDRHandQeEZEVzdJLXpRM0xOS09rSkJsOVN5ek50VFZSZndOZkM1SnBrejE4QW1rdUJwM1YtanN2REZFbzdjSnVDUUFoMG5RVU1CSDA4TTA1NzNxZ3VuSnVIQzlGbkM1ZVdsZFhWYXFmNkdzdGhwR0dzZEdiWExLbFhUcm9CRXZfUzFCRG5qSGpaSUFwazJDZjREVEpkZk9JSHMxQmtuN3NLaGY3VVltNU1aWVFtODM2eFdsSHFFcU0yUkhrUV9oZ1djNDhCcTFYNjRaWm1NUl90amJlOXhrcFZTSzg0Q2VNVXlObEQ0akdEWmh6cm5SNXk4dWJnVWZULWtVYVJiS2VZQ1hXZFQ4aTRGcU41WF92XzBXck9NWkNvMm9WYVZ3?oc=5","date":"2024-09-23","type":"pipeline","source":"BioSpace","summary":"Italian Studies Confirm Safety of HOPE (Hypothermic Oxygenated PErfusion) for Liver Transplantation and Value of HOPE in Identifying Biomarkers for Assessing Liver Viability - BioSpace","headline":"Italian Studies Confirm Safety of HOPE (Hypothermic Oxygenated PErfusion) for Liver Transplantation and Value of HOPE in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE4yNkZ6NWl1eGx0U3dGcExBWlRpNjJwY3BnZU1Ra1cxRVNQTkJJamhzdjNpWVBIVFNZSmJzcXFwSmw2Y3FJQmVvVm9KdTVobkp3aDRtemgzS19hTVppYWlTWmV4aW4tUzZlelQw?oc=5","date":"2023-10-07","type":"pipeline","source":"Wiley Online Library","summary":"Association between neurodevelopmental impairments and motor function in Duchenne muscular dystrophy - Wiley Online Library","headline":"Association between neurodevelopmental impairments and motor function in Duchenne muscular dystrophy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5sOEdBNGRwWnMtNHRsLVVHV2VERG9xNjYtTWZoRU96endnOTRFem9XcUFMUXVYQWpsR2tHN2MwTnplTmxYcmhtazI1dnJBRzBIMkZxUzZxb0lpV3BwSnA0?oc=5","date":"2021-12-10","type":"regulatory","source":"nature.com","summary":"Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology - nature.com","headline":"Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1mRkFTdGVha19ZNTdLWHhRVTRTMHoyLVkwa2F1UXVZcFFyZmpsMnByQnNyYktldXhnMUVhRnhJdS1YcC1MLWdEQ2RqWkRzR0RJSTl6U3dXS1k2Y1RIQ2dF?oc=5","date":"2019-07-23","type":"pipeline","source":"nature.com","summary":"Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvascular injury - nature.com","headline":"Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvasc","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":1,"phase_2":1,"marketed":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}